An Act to amend the Food and Drugs Act (substances in menstrual tampons)
Bill C-366 was a Liberal Private Member's Bill amending the Food and Drugs Act (R.S.C. 1985, c. F-27) to require disclosure of all substances in menstrual tampons and pads sold in Canada. Brought after the Environmental Defence Canada 2022 report documented per- and polyfluoroalkyl substances (PFAS, the forever chemicals) in several brands of menstrual products sold in Canada. Health Canada's Food and Drug Regulations currently classify tampons as Class II medical devices but do not require ingredient-list disclosure to consumers. The bill would have required full ingredient disclosure parallel to US FDA voluntary guidelines and the EU REACH regulation. Did not pass second reading.
Status
Quick learn
Would require makers of tampons and pads sold in Canada to disclose all their ingredients, after a 2022 report found PFAS forever chemicals in several brands. Health Canada does not currently require an ingredient list. A Liberal private member's bill; it did not pass second reading.
Issues this bill touches
- Gender Equality & Reproductive Rights
Food and Drugs Act on substances in menstrual tampons.
Legislative history
- First reading
First reading in the House of Commons.
View source
Official source
Read full text on Parliament of Canada